Epinephrine
| Adrenaline | |
|---|---|
| Salts [] | |
|---|---|
| Epinephrine sulfate | |
| Epinephrine acetate | |
| Epinephrine bitartrate | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 183.20 g/mol [1] |
| Appearance | Brown (in air) [1] |
| Odor | Odorless [1] |
| Melting point | 412 to 414 °F (NTP, 1992) [1] |
| Boiling point | 215 [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of /nitrogen oxides/. [1] |
| Solubility | less than 0.1 mg/mL at 64 °F (NTP, 1992) [1] |
| Predicted LogP | -1.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C9H13NO3 |
| IUPAC name | 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol |
| SMILES | CNC[C@@H](C1=CC(=C(C=C1)O)O)O |
| InChI | InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1 |
| InChIKey | UCTWMZQNUQWSLP-VIFPVBQESA-N |
| CAS number | 51-43-4 |
| UNII | YKH834O4BH |
| PubChem CID | 5816 |
| Toxicity [] | |
|---|---|
| LD50 | Rat: - dermal: 62 mg/kg - sc: 62 mg/kg - iv: 0.15 mg /kg - im: 3500 mg/kg [1] |
Epinephrine (also known as l-Adrenaline, Adrenalin, Levoepinephrine, Nephridine, Epinefrina, Epipen, Adnephrine, Chelafrin, Epinephran or (-)-Adrenaline) is a neurotransmitters substance of the catecholamine and phenylethanolamine class.
Chemistry
Salts []
Stereochemistry []
Epinephrine is a single defined stereoisomer (optical activity ( - )).
Druglikeness
Lipinski's rule of five
Epinephrine matches Lipinski's rule of five.Pharmacology
ATC Classification
- alimentary tract and metabolism (A)
- stomatological preparations (A01)
- stomatological preparations (A01A)
- other agents for local oral treatment (A01AD)
- epinephrine (A01AD01)
- blood and blood forming organs (B)
- antihemorrhagics (B02)
- vitamin k and other hemostatics (B02B)
- local hemostatics (B02BC)
- epinephrine (B02BC09)
- cardiovascular system (C)
- cardiac therapy (C01)
- cardiac stimulants excl. cardiac glycosides (C01C)
- adrenergic and dopaminergic agents (C01CA)
- (C01CA24)
- epinephrine (C01CA24)
- (C01CA24; R03AA01; S01EA01)
- respiratory system (R)
- nasal preparations (R01)
- decongestants and other nasal preparations for topical use (R01A)
- sympathomimetics, plain (R01AA)
- epinephrine (R01AA14)
- drugs for obstructive airway diseases (R03)
- adrenergics, inhalants (R03A)
- alpha- and beta-adrenoreceptor agonists (R03AA)
- epinephrine (R03AA01)
- sensory organs (S)
- ophthalmologicals (S01)
- antiglaucoma preparations and miotics (S01E)
- sympathomimetics in glaucoma therapy (S01EA)
- epinephrine (S01EA01)
MeSH Classification
- adrenergic alpha-agonists (M0000492)
- adrenergic beta-agonists (M0000494)
- bronchodilator agents (M0002975)
- mydriatics (M0014317)
- sympathomimetics (M0020947)
- vasoconstrictor agents (M0022551)
Mechanism of action []
Epinephrine acts on alpha and beta-adrenergic receptors. Epinephrine acts on alpha and beta receptors and is the strongest alpha receptor activator. Through its action on alpha-adrenergic receptors, epinephrine minimizes the vasodilation and increased the vascular permeability that occurs during anaphylaxis, which can cause the loss of intravascular fluid volume as well as hypotension. Epinephrine relaxes the smooth muscle of the bronchi and iris and is a histamine antagonist, rendering it useful in treating the manifestations of allergic reactions and associated conditions. This drug also produces an increase in blood sugar and increases glycogenolysis in the liver. Through its action on beta-adrenergic receptors, epinephrine leads to bronchial smooth muscle relaxation that helps to relieve bronchospasm, wheezing, and dyspnea that may occur during anaphylaxis. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| ADRB2 | shared target | 320 (210 contraindicated) |
|---|---|---|
| ADRB1 | shared target | 246 (90 contraindicated) |
| ADRA1A | shared target | 228 (194 contraindicated) |
| ADRA1B | shared target | 212 (178 contraindicated) |
| ADRA1D | shared target | 212 (178 contraindicated) |
| ADRA2A | shared target | 176 (162 contraindicated) |
| ADRA2B | shared target | 172 (158 contraindicated) |
| ADRA2C | shared target | 170 (156 contraindicated) |
| ADRB3 | shared target | 160 (82 contraindicated) |
| COMT | metabolism | 22 (22 contraindicated) |
| MAO | metabolism | 14 (14 contraindicated) |
Medical side effects []
72 side effects listed on drug labels in SIDER 4.1 (epinephrine).
- Lactic acidosis
- Arrhythmia
- Mental disorder
- Chest pain
- Contusion
- Somnolence
- Extravasation
- Flushing
- Gas gangrene
- Gastrointestinal disorder
- Hallucination
- Hemiplegia
- Haemorrhage
- Haemoglobin
- Hyperglycaemia
- Hypoaesthesia
- Hypoglycaemia
- Hypokalaemia
- Ischaemia
- Nephropathy
- Mydriasis
- Myocardial infarction
- Acute coronary syndrome
- Nausea
- Necrosis
- Nervous system disorder
- Nervousness
- Tension
- Palpitations
- Panic reaction
- Paraesthesia
- Tingling sensation
- Piloerection
- Psychotic disorder
- Pulmonary oedema
- Rales
- Cerebrovascular accident
- Subarachnoid haemorrhage
- Hyperhidrosis
- Sweating increased
- Tachycardia
- Supraventricular tachycardia
- Erythema
- Redness of face
- Ventricular fibrillation
- Vomiting
- Tachyarrhythmia
- Ventricular arrhythmia
- Ventricular extrasystoles
- Myocardial ischaemia
- Skin necrosis
- Skin exfoliation
- Skin disorder
- Dizziness
- Disorientation
- Memory impairment
- Agitation
- Peripheral coldness
- Pallor
- Blood pressure increased
- Skeletal injury
- Drug interaction
- Feeling cold
- Local reaction
- Hypertension
- Insomnia
- Renal failure
- Renal impairment
- Injection site pallor
- Injection site injury
- Cerebral haemorrhage
- Central nervous system haemorrhage
Indications
- Acute sinusitis
- Adams-Stokes syndrome
- Agitation
- Anaphylactic shock
- Anaphylactoid reaction
- Angina pectoris
- Angioedema
- Anxiety
- Asthenia
- Asthma
- Atrioventricular block complete
- Bite
- Block heart
- Bronchospasm
- Cardiac arrest
- Cardiac disorder
- Cardiovascular disorder
- Carotid sinus hypersensitivity
- Convulsion
- Coronary artery disease
- Diabetic
- Dizziness
- Dyspnoea
- Exercise-induced anaphylaxis
- Glaucoma
- Headache
- Hypersensitivity
- Hypertension
- Hyperthyroidism
- Hypotension
- Laryngospasm
- Pallor
- Parkinson's disease
- Pruritus
- Rash
- Respiratory distress
- Rhinitis
- Seasonal allergy
- Serum sickness
- Shock insulin
- Sting
- Stinging
- Syncope
- Throbbing headache
- Tremor
- Urticaria
- Uterine contractions
Experience reports
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5816, Epinephrine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5816
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Epinephrine. UNII: YKH834O4BH. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/YKH834O4BH
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 06:46:08 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 06:46:04 |
| erowid | ok | 2026-11-20 06:46:09 |
| gsrs | ok | 2026-11-20 06:46:07 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0000068) | 2026-11-20 06:46:04 |
| kegg | ok | 2026-11-20 06:46:08 |
| pubchem | ok | 2026-11-20 06:46:04 |
| ok | 2026-11-20 06:46:04 | |
| sider | ok | 2026-11-20 06:46:04 |
| structure | ok | 2026-11-20 06:46:04 |
| wikipedia | missing (no Wikipedia article with a drug infobox) | 2026-11-20 06:46:04 |